Evaluation: Body fat (DXA scanning) Lean mass Insulin sensitivity Energy expenditure What they found: The combination showed an additive effect on fat reduction vs monotherapy AOD-9604 partially protected lean mass during GLP-1-induced weight reduction Increased energy expenditure in combination (~3 % vs GLP-1 alone) No new safety signals Why it matters: It validates the concept of combination , the idea that AOD-9604 may not work on its own, but can add value in combination with incretin agonists
Ferroptosis in musculoskeletal diseases Musculoskeletal diseases, such as osteoarthritis, osteoporosis, sarcopenia, and amyotrophic lateral sclerosis, seriously impair patients quality of life and place a substantial strain on global public health resources
Because cancer cells require significant blood supply to grow and metastasize, adipotides targeting of prohibitin in those cells without harming surrounding tissue makes it a candidate for further research in this field [7]
Precautions: Consult your doctor or dermatologist before using any product that contains ingredients such as Alpha-Arbutin or Glutathione, as they may not be safe for use during pregnancy and breastfeeding